Journals / Current Perspectives on Medicinal and Aromatic Plants / 2022 / Cilt: 5 - Sayı: 2

Anti-Acetylcholinesterase and Synergistic Antifungal Activities of Selected Salvia Species: Correlation with Metabolic Profiles

Pages
136–145
Publication Date
2023-01-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to investigate active metabolites according to correlation results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Salvia species are known for their anti-fungal and anti-acetylcholinesterase (AChE) activity.
📊
Key Findings & Data:Also, Ellman's spectrophotometric method for anti-acetylcholinesterase activity and the checkerboard method for synergistic antifungal activity between extracts and fluconazole were performed. 295 known and 1408 unknown metabolites were detected in GC-MS while 346 known and 69008 unknown metabolites in LC-QTOF-MS.
💡
Conclusion & Impact:Further studies are needed to investigate active metabolites according to correlation results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Acetylcholinesterase inhibitory activity · Metabolomics · Salvia

Abstract

Salvia species are known for their anti-fungal and anti-acetylcholinesterase (AChE) activity. Metabolomics is defined as a comprehensive quantitative and qualitative analysis of large-scale metabolites. In this study, besides determining anti-acetylcholinesterase and synergistic antifungal activities of selected Salvia species (S. cryptantha, S. tchihatcheffii, S. officinalis, S. virgata), the metabolite profiles were clarified and correlation analyzes between the activity results and profiles were carried out. Aerial parts of all plant materials were extracted by methanol to determine the metabolic profile by using GC-MS (Gas Chromatography-Mass Spectrometry) and LC-QTOF-MS (Liquid Chromatography Quadrupole Time of Flight Mass Spectrometry). Also, Ellman's spectrophotometric method for anti-acetylcholinesterase activity and the checkerboard method for synergistic antifungal activity between extracts and fluconazole were performed. 295 known and 1408 unknown metabolites were detected in GC-MS while 346 known and 69008 unknown metabolites in LC-QTOF-MS. S. cryptantha, S. tchihatcheffii, S. officinalis, and S. virgata demonstrated inhibitory activities on AChE with the ratio of 32.72%, 5.9%, 43.96%, and 12.1% at the concentration of 200 µg/m and a synergism was found for all Salvia sp. against Candida tropicalis ATCC 750 strain with the FICI values of 0.28, 0.15, 0.10, 0.5 respectively. In addition, as a result of correlation analysis, 73 metabolites positively and 31 metabolites negatively correlated with anti-acetylcholinesterase activity, while 18 metabolites positively, and 117 metabolites negatively correlated with synergistic activity were found. All Salvia species exhibited synergic activity with fluconazole while having weak AChE inhibitory activity. Combining natural products with synthetic drugs is important in order to increase efficacy. At the same time, herbal products must be used carefully at the point of herb-drug interactions. Further studies are needed to investigate active metabolites according to correlation results.

🔖

Cite This Article

YARDIMCI, G. B., BALTACI, N., KAHRAMAN, Ç., GÖNÜLALAN, E. M. (2023). Anti-Acetylcholinesterase and Synergistic Antifungal Activities of Selected Salvia Species: Correlation with Metabolic Profiles. Current Perspectives on Medicinal and Aromatic Plants, Cilt: 5 - Sayı: 2, 136–145. https://ajindex.com/articles/867610

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ahmad, A., Khan, A., & Manzoor, N. (2013). Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. European Journal of Pharmaceutical Sciences, 48(1-2), 80-86. DOI:10.1016/j.ejps.2012.09.016 2. Alkhalifa, B. A., Bulatova, N. R., & Darwish, R. M. (2022). Serotonin reuptake inhibitors effect on fluconazole activity against resistant Candida glabrata strains. Journal of Global Antimicrobial Resistance, 29, 49-54. DOI:10.1016/j.jgar.2022.01.030 3. Amaro-Luis, J. M., Herrera, J. R., & Luis, J. G. (1998). Abietane diterpenoids from Salvia chinopeplica. Phytochemistry, 47(5), 895-897. 4. Arastehfar, A., Hilmioğlu-Polat, S., Daneshnia, F., Hafez, A., Salehi, M., Polat, F.,. & Lass-Flörl, C. (2020). Recent increase in the prevalence of fluconazole-non-susceptible Candida tropicalis blood isolates in Turkey: Clinical implication of azole-non-susceptible and fluconazole tolerant phenotypes and genotyping. Frontiers in microbiology, 11, 587278. DOI: 10.3389/fmicb.2020.587278 5. Bibi, M., Murphy, S., Benhamou, R. I., Rosenberg, A., Ulman, A., Bicanic, T.,. & Berman, J. (2021). Combining colistin and fluconazole synergistically increases fungal membrane permeability and antifungal cidality. ACS infectious diseases, 7(2), 377-389. DOI:10.1021/acsinfecdis.0c00721 6. Björkholm, C., & Monteggia, L. M. (2016). BDNF--a key transducer of antidepressant effects. Neuropharmacology, 102, 72-79. DOI:10.1016/j.neuropharm.2015.10.034 7. Canturk, Z. (2018). Evaluation of synergistic anticandidal and apoptotic effects of ferulic acid and caspofungin against Candida albicans. journal of food and drug analysis, 26(1), 439-443. DOI: 10.1016/j.jfda.2016.12.014 8. Clinical and Laboratory Standards Institute (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Third Edition: Approved Standard M27-A3; CLSI: Wayne, PA, USA,; Volume 28. 9. Ellman, G. L., Courtney, K. D., Andres Jr, V., & Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical pharmacology, 7(2), 88-95 10. Ermenlieva, N., Georgieva, E., Mihaylova, S., Stamova, S., Laleva, K., Tsankova, G., & Tsvetkova, A. (2022). Synergistic Interaction Between Lamiaceae Essential Oils and Antifungal Drugs Against Candida albicans Atcc 10231. biofilms, 70, 4:720-725. DOI: 10.31925/farmacia.2022.4.18 11. Gonulalan, E. M., Nemutlu, E., Bayazeid, O., Kocak, E., Yalçın, F. N., & Demi